Delcayre; Alain

Patent Applications and Registrations

Patent applications and USPTO patent grants for Delcayre; Alain.The latest application filed is for "combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist of an immune checkpoint inhibitor".

Company Profile

0.10.15

Delcayre; Alain - San Jose CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist of an Immune Checkpoint Inhibitor App 20210205429 - Foy; Susan ; et al.	2021-07-08
Therapeutic Agents Specifically Delivered By Exosomes For Cancer Treatment App 20210161817 - Wang; Jing-Hung ; et al.	2021-06-03
Promoters For Enhancing Expression In Poxviruses App 20180216134 - Li; Zengji ; et al.	2018-08-02
Combination Therapy for Treating Cancer with a Poxvirus Expressing a Tumor Antigen and an Antagonist and/or Agonist of an Immune Checkpoint Inhibitor App 20160271239 - FOY; SUSAN ; et al.	2016-09-22
Methods And Compositions For The Treatment Of Cancer App 20150283220 - Mandl; Stefanie ; et al.	2015-10-08
Use of MVA to treat prostate cancer Grant 8,377,688 - Delcayre , et al. February 19, 2	2013-02-19
Methods for treating cancer with a recombinant MVA expressing HER-2 Grant 8,313,740 - Delcayre , et al. November 20, 2	2012-11-20
Methods and compounds for raising antibodies and for screening antibody repertoires Grant 7,914,792 - Delcayre , et al. March 29, 2	2011-03-29
Use Of Mva To Treat Prostate Cancer App 20110008386 - DELCAYRE; Alain ; et al.	2011-01-13
Methods For Treating Cancer With Mva App 20110008294 - DELCAYRE; Alain ; et al.	2011-01-13
Use of MVA to treat prostate cancer Grant 7,867,483 - Delcayre , et al. January 11, 2	2011-01-11
Methods for treating cancer with a recombinant MVA expressing HER-2 Grant 7,807,146 - Delcayre , et al. October 5, 2	2010-10-05
Methods and compounds for the targeting of protein to exosomes Grant 7,704,964 - Delcayre , et al. April 27, 2	2010-04-27
Exosome Ligands, Their Preparation And Uses App 20090148460 - Delcayre; Alain ; et al.	2009-06-11
Use Of Mva To Treat Prostate Cancer App 20090104225 - Delcayre; Alain ; et al.	2009-04-23
Methods for treating cancer with MVA App 20080213302 - Delcayre; Alain ; et al.	2008-09-04
Compounds for treatment of infectious and immune system disorders and methods for their use Grant 7,192,590 - Delcayre March 20, 2	2007-03-20
Methods and compounds for raising antibodies and for screening antibody repertoires App 20060222654 - Delcayre; Alain ; et al.	2006-10-05
Compounds for treatment of infectious and immune system disorders and methods for their use Grant 7,041,295 - Delcayre May 9, 2	2006-05-09
Compositions isolated from M. vaccae and their use in the modulation of immune responses App 20050214320 - Delcayre, Alain	2005-09-29
Methods and compounds for the targeting of protein to exosomes App 20040197314 - Delcayre, Alain ; et al.	2004-10-07
Compounds for treatment of infectious and immune system disorders and methods for their use App 20040072224 - Delcayre, Alain	2004-04-15
Compositions isolated from M. vaccae and their use in the modulation of immune responses Grant 6,716,430 - Delcayre April 6, 2	2004-04-06
Compounds for treatment of infectious and immune system disorders and methods for their use App 20030054013 - Delcayre, Alain	2003-03-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.